Upfront PSMA PET imaging detects hidden metastases in early prostate cancer, altering treatment plans in up to one-third of ...

Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population; PSMAddition ...

It’s important to understand how radiation therapy fits into your prostate cancer treatment plan. This information can help you make choices about your care. Radiation therapy works by using ...

Today:Early fog in the far southwest clears quickly. Most areas stay dry with sunshine and variable cloud, though northern and northeastern regions may see isolated showers. Light winds overall, ...

Plan adaptation Reference pseudo-CT image overlaid with the dose distribution (left) and a CBCT with the adapted dose distribution (right), in the axial (top) and coronal (bottom) views. Target ...

The primary end points were FISST and local control (LC) rates of lesions that received SBRT. The secondary end point was overall survival (OS) after SBRT. To calculate FISST, event was defined as the ...

Systemic therapies for metastatic castration-resistant prostate cancer (mCRPC) include androgen deprivation therapy (ADT) (1), androgen receptor pathway inhibitors (ARPIs) (2–5), chemotherapy (6,7), ...

aCenter for Health Decision Science, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA bDepartment of Health Policy and Management, Harvard T H Chan School of Public Health ...

Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242470; Results: Among the six patients, assuming each was administered 7.4 GBq 177 Lu-PSMA-617, the min and max mean absorbed doses for the ...